MEDLINE INC-CL A
MDLNNASDAQTrading Snapshot
- Day Range
- $32.06 β $32.72
- 52-Week Range
- $31.49 β $50.88
- Volume (shares)
- 8,153,437
- Avg Volume (shares)
- β
- Shares Outstanding
- 877.4M
- Next Earnings
- 2026-11-04
Fundamentals Snapshot
- Annual Revenue
- $28.43B
- Last Q Revenue
- $7.68B
- P/E Ratio
- 37.6
- P/S Ratio
- 0.9x
- EPS (TTM)
- $0.81
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +3.2%
MEDLINE INC-CL A
MDLNAbout MEDLINE INC-CL A
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates

$MDLN Stock Market Alert: Medline Investigated for Securities Fraud after Product Quality Issues Lead to 13% Stock Drop β Contact BFA Law if You Lost Money
NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Leading securities law firmΒ Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock dr

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN
NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Medline Inc. (βMedlineβ or the βCompanyβ) (NASDAQ: MDLN). Such investors are advised to contact Danielle Peyton

$MDLN Stock Losses: BFA Law Reminds Medline Investors with Losses of the Ongoing Securities Fraud Investigation into Potential Product Quality Misrepresentations
NEW YORK, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock dro

MDLN Investigation News: Medline Investors are Notified of the Pending Securities Fraud Investigation β Contact BFA Law if You Lost Money
NEW YORK, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock dro

MDLN Loss Notice: Medline Investors are Reminded of the Pending Securities Fraud Investigation β Contact BFA Law if You Lost Money
NEW YORK, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Leading securities law firmΒ Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock dr

MDLN Investigation Reminder: Medline Investors that Lost Money after the 13% Stock Drop are Notified to Contact BFA Law
NEW YORK, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Medline Inc. (NASDAQ:MDLN) for potential securities fraud after its significant stock dro